The bioconvergence market has experienced rapid growth, with predictions of reaching $159.66 billion in 2025 and $243.53 billion in 2029. This growth is fueled by personalized medicine, biomedical engineering advancements, and increased healthcare digitization. Innovative trends like AI in drug discovery and lab-on-a-chip technologies are shaping the industry. Major drivers include the emphasis on personalized […]
Tag: tissue
AI’s Impact on Precision Oncology by 2025
The advent of the information era has ushered in an unprecedented revolution in many fields, with the healthcare sector being no exception to this. In the realm of precision oncology, the latest protagonist is Generative AI, a technology possessing computational capabilities so powerful that they are reshaping the landscape of cancer therapeutics. It is a […]
AP-1 TFs and SWI/SNF in Enhancer Selection
In the intricate symphony of cellular function, the recent research conducted by Thomas Vierbuchen, Ph.D., and his team from the Department of Molecular & Systems Biology at the Geisel School of Medicine at Dartmouth, has spotlighted a key player – AP-1 transcription factors (TFs). Their findings provide not only a deeper understanding of enhancer selection […]
AAV Gene Therapy Vectors for Hemophilia
Recent research explores the theoretical risk of hepatocellular carcinoma (HCC) following adeno-associated virus (AAV) gene therapy in hemophilia patients. While data from clinical trials are reassuring, concerns remain about long-term oncogenic potential. A single case of HCC post AAV infusion in a patient with prior HCV infection raised questions, but further analysis suggested AAV integration […]